Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Current Deferred Revenue (2020 - 2025)

Doximity (DOCS) has disclosed Current Deferred Revenue for 6 consecutive years, with $66.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 4.18% to $66.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $66.3 million, a 4.18% decrease, with the full-year FY2025 number at $114.3 million, up 15.27% from a year prior.
  • Current Deferred Revenue was $66.3 million for Q4 2025 at Doximity, down from $100.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $117.4 million in Q2 2025 to a low of $65.6 million in Q4 2021.
  • A 5-year average of $88.7 million and a median of $90.5 million in 2022 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 87.26% in 2021, then dropped 5.97% in 2024.
  • Doximity's Current Deferred Revenue stood at $65.6 million in 2021, then increased by 6.24% to $69.7 million in 2022, then decreased by 4.27% to $66.7 million in 2023, then grew by 3.75% to $69.2 million in 2024, then fell by 4.18% to $66.3 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Current Deferred Revenue are $66.3 million (Q4 2025), $100.0 million (Q3 2025), and $117.4 million (Q2 2025).